Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000068

Director acquired 3,976 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-07-03 Grant or award : show line 1 in the form +3,976 $2.83 $11,252 102,620 D
Loading xslF345X04/wk-form4_1688588720.xml…